N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide
概述 用途与合成方法 MSDS N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide价格(试剂级) 上下游产品信息
| 中文名称 | N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide |
|---|---|
| 中文同义词 | 化合物EMLENOFLAST;N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-1-(1-甲基乙基)-1H-吡唑-3-磺酰胺;N-((1,2,3,5,6,7-六氢-s-indacen-4-基)氨基甲酰基)-1-异丙基-1H-吡唑-3-磺酰胺 |
| 英文名称 | N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide |
| 英文同义词 | N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide;1H-Pyrazole-3-sulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-1-(1-methylethyl)-;MCC7840 sodium;Emlenoflast;MCC7840;N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamide;MCC 7840,sulfonylurea,Emlenoflast,NLRP3,inhibit,NOD-like Receptor (NLR),MCC-7840,inflammatory,inflammasome,Inhibitor;Inzomelid |
| CAS号 | 1995067-59-8 |
| 分子式 | C19H24N4O3S |
| 分子量 | 388.48 |
| EINECS号 | |
| 相关类别 | 抑制剂 |
| Mol文件 | 1995067-59-8.mol |
| 结构式 | ![N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide 结构式](CAS/20210111/GIF/1995067-59-8.gif) |
N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide 性质
| 密度 | 1.46±0.1 g/cm3(Predicted) |
|---|---|
| 储存条件 | Store at -20°C |
| 形态 | 固体 |
| 酸度系数(pKa) | 1.50±0.10(Predicted) |
| 颜色 | 白色至米白色 |
N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide 用途与合成方法
Emlenoflast (MCC7840)，一种磺酰脲类，是一种有效和选择性的 NLRP3 炎症小体 (NLRP3 inflammasome) 抑制剂，IC50 值小于 100 nM。Emlenoflast 可用于炎性疾病的研究。
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2025/12/22 | HY-137245 | Emlenoflast | 1995067-59-8 | 5 mg | 2800元 |
| 2025/12/22 | HY-137245 | Emlenoflast | 1995067-59-8 | 10 mg | 4200元 |